Article
Increased sensitivity to the antimalarials mefloquine and artemisinin is conferred by mutations in the <i>pfmdr1</i> gene of <i>Plasmodium falciparum</i>
1 May 2000
Abstract excerpt
The declining efficacy of chloroquine and pyrimethamine/sulphadoxine in the treatment of human malaria has led to the use of newer antimalarials such as mefloquine and artemisinin. Sequence polymorphisms in the pfmdr1 gene, the gene encoding the plasmodial homologue of mammalian multidrug resistance transporters, have previously been linked to resistance to chloroquine in some, but not all, studies. In this...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
